Endoscopic stenting of dominant strictures in patients with primary sclerosing cholangitis: When, how, and for how long?

Il Sang Shin; Jong Ho Moon

doi:10.1055/a-1916-8992

Endoscopy International Open, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Endosc Int Open 2022; 10(09): E1169-E1171
DOI: 10.1055/a-1916-8992

Editorial

Endoscopic stenting of dominant strictures in patients with primary sclerosing cholangitis: When, how, and for how long?

Il Sang Shin

¹Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine, Bucheon, Korea

,

Jong Ho Moon

¹Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine, Bucheon, Korea

References
1 Dyson JK, Beuers U, Jones DEJ. et al. Primary sclerosing cholangitis. Lancet 2018; 391: 2547-2559
2 Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med 2016; 375: 1161-1170
3 Rizvi S, Eaton JE, Gores GJ. Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management. Clin Gastroenterol Hepatol 2015; 13: 2152-2165
4 Kaya M, Petersen BT, Angulo P. et al. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001; 96: 1059-1066
5 Gluck M, Cantone NR, Brandabur JJ. et al. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol 2008; 42: 1032-1039
6 Ponsioen CY, Arnelo U, Bergquist A. et al. No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis. Gastroenterology 2018; 155: 752-759
7 Gotthardt DN, Rudolph G, Klöters-Plachky P. et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 2010; 71: 527-534
8 Ponsioen CY, Lam K, van Milligen de Wit AW. et al. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 2403-2407
9 van Milligen de Wit AW, Rauws EA, van Bracht J. et al. Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1997; 46: 344-347
10 Ismail S, Kylänpää L, Mustonen H. et al. Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy 2012; 44: 1133-1138
11 Sbeit W, Khoury T, Goldin E. et al. Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety. Surg Endosc 2022; 36: 2412-2417
12 Ferreira M, Ribeiro IB, de Moura DTH. et al. Stent versus balloon dilation for the treatment of dominant strictures in primary sclerosing cholangitis: a systematic review and meta-analysis. Clin Endosc 2021; 54: 833-842
13 Aabakken L, Karlsen TH, Albert J. et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy 2017; 49: 588-608